Figure 2.
Best change in %FEV1 from baseline while on belumosudil therapy. Dotted lines mark absolute improvement by 5% and 10%, respectively. Baseline NIH lung score are indicated by color. Each bar represents an individual subject.
Best change in %FEV1 from baseline while on belumosudil therapy. Dotted lines mark absolute improvement by 5% and 10%, respectively. Baseline NIH lung score are indicated by color. Each bar represents an individual subject.
